BW Communities

Articles for Healthcare

Govt Allows Serum Institute To Export 50L Covishield Doses To 4 Nations

In addition to these three countries, the SII will also export Covishield to Bangladesh under COVAX, they said.

Read More
Zydus Cadila Gets USFDA Nod To Market Generic Cancer Drug In US

Decitabine is used to treat myelodysplastic syndromes, certain types of blood or bone marrow cancer.

Read More
110 Nations Agree To Recognise India's Covid Vaccine Certificates: Report

The Union government continues to be in communication with the rest of the world so that beneficiaries of the world's largest COVID-19 vaccination program are accepted and recognised, thereby easing travel for education, business and tourism purposes.

Read More
Zydus Cadila Gets USFDA Green Signal For Cancer Drug With 180 Days Exclusivity

The company has received approval from the US Food and Drug Administration (USFDA) for the Nelarabine injection 250 MG/50ML, a generic version of Arranon injection.

Read More
India’s COVID-19 Vaccination Coverage Exceeds 113 Cr Mark

The active caseload is presently at 1,28,555 which is the lowest in 527 days. Active cases presently constitute 0.37 per cent of the country's total positive cases, which is the lowest since March 2020.

Read More
WFH Policy, Ban On Industries Being Mulled To Tackle Air Pollution In National Capital

"On Monday, DPCC teams went to see whether the measures are being implemented and they found that the construction work has been stopped," Rai told reporters.

Read More
India’s Cumulative COVID-19 Vaccination Coverage Exceeds 112 Cr Mark

"Active cases presently constitute 0.39 per cent of the country's total positive cases, which is the lowest since March 2020," the ministry said.

Read More
Here You All Need To Know About Pfizer's COVID-19 Treatment Pill

The phase 2/3 trial data on which those hospitalisation rates are based have yet to be independently verified. Nor has the treatment been approved by any country for use outside a clinical trial.

Read More

Subscribe to our newsletter to get updates on our latest news